DK0758890T3 - Anvendelse af NO indfangere, inhibitorer eller antagonister ved behandling af migræne - Google Patents

Anvendelse af NO indfangere, inhibitorer eller antagonister ved behandling af migræne

Info

Publication number
DK0758890T3
DK0758890T3 DK95918128T DK95918128T DK0758890T3 DK 0758890 T3 DK0758890 T3 DK 0758890T3 DK 95918128 T DK95918128 T DK 95918128T DK 95918128 T DK95918128 T DK 95918128T DK 0758890 T3 DK0758890 T3 DK 0758890T3
Authority
DK
Denmark
Prior art keywords
migraine
treatment
catchers
antagonists
inhibitors
Prior art date
Application number
DK95918128T
Other languages
Danish (da)
English (en)
Inventor
Jes Olesen
Original Assignee
Jes Olesen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jes Olesen filed Critical Jes Olesen
Application granted granted Critical
Publication of DK0758890T3 publication Critical patent/DK0758890T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
DK95918128T 1994-05-11 1995-05-10 Anvendelse af NO indfangere, inhibitorer eller antagonister ved behandling af migræne DK0758890T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94610027 1994-05-11
PCT/IB1995/000415 WO1995031195A1 (en) 1994-05-11 1995-05-10 Use of no scavengers, inhibitors or antagonists in the treatment of migraine
EP95918128A EP0758890B1 (de) 1994-05-11 1995-05-10 Verwendung der no-faenger, inhibitoren oder antagonisten zur behandlung von migraene

Publications (1)

Publication Number Publication Date
DK0758890T3 true DK0758890T3 (da) 2005-04-18

Family

ID=8218183

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95918128T DK0758890T3 (da) 1994-05-11 1995-05-10 Anvendelse af NO indfangere, inhibitorer eller antagonister ved behandling af migræne

Country Status (12)

Country Link
US (1) US6265441B1 (de)
EP (1) EP0758890B1 (de)
JP (2) JPH10500129A (de)
AT (1) ATE291909T1 (de)
AU (1) AU704059B2 (de)
CA (1) CA2189762C (de)
DE (1) DE69534118T2 (de)
DK (1) DK0758890T3 (de)
ES (1) ES2238074T3 (de)
PT (1) PT758890E (de)
SI (1) SI0758890T1 (de)
WO (1) WO1995031195A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998019674A2 (en) * 1996-11-05 1998-05-14 Head Explorer Aps A method for treating tension-type headache
US6284794B1 (en) 1996-11-05 2001-09-04 Head Explorer Aps Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase
AU1824300A (en) * 1998-11-23 2000-06-13 Linden Biotechnology, Inc. Combination products of a guanylate cyclase inhibitor and a local anesthetic forpain relief
EP1562975A2 (de) * 2002-10-25 2005-08-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroide welche gruppen zur nachahmung von superoxidase dismutase sowie stickoxid donorgruppen beinhalten und ihre verwendung in der darstellung von medikamenten
EP1578413A2 (de) * 2002-11-29 2005-09-28 Yissum Research Development Company of The Hebrew University of Jerusalem Ace-hemmer mit antioxidativer und no-donor-wirkung
US20080274206A1 (en) * 2004-10-07 2008-11-06 Ngen Pharmaceuticals N.V. Stabilised Oxygen Releasing Composition
WO2007009462A2 (en) * 2005-07-15 2007-01-25 Region Hovedstaden V/Glostrup Hospital Treatment of migraine and headaches
US20090191283A1 (en) * 2008-01-24 2009-07-30 Oronsky Bryan Todd Treatment of headaches, neck pain, joint pain and inflammatory-type pain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
FR2707494B1 (fr) 1993-07-02 1995-08-25 Roussel Uclaf Nouvelle utilisation de dérivés de la béta-naphtoquinone ainsi que de leurs sels.
BR9407515A (pt) 1993-08-12 1997-01-07 Astra Ab Composto formulação farmaceutica uso do composto processos para o tratamento de desordens neurodegenerativas ou de enxaqueca ou para a prevenção e a reversão da tolerância aos opiatos e diazepinas ou para o tratamento do vicio das drogas e para a preparação do composto
GB9317686D0 (en) * 1993-08-25 1993-10-13 Johnson Matthey Plc Pharmaceutical compositions
EP0759027B1 (de) * 1994-05-07 1999-08-04 Astra Aktiebolag Bicyclische amidinderivate als no-synthetase inhibitoren

Also Published As

Publication number Publication date
JP2007137906A (ja) 2007-06-07
CA2189762C (en) 2009-01-13
DE69534118D1 (de) 2005-05-04
EP0758890B1 (de) 2005-03-30
ATE291909T1 (de) 2005-04-15
WO1995031195A1 (en) 1995-11-23
AU2417995A (en) 1995-12-05
SI0758890T1 (de) 2005-08-31
ES2238074T3 (es) 2005-08-16
EP0758890A1 (de) 1997-02-26
US6265441B1 (en) 2001-07-24
PT758890E (pt) 2005-06-30
JPH10500129A (ja) 1998-01-06
CA2189762A1 (en) 1995-11-23
DE69534118T2 (de) 2006-02-09
AU704059B2 (en) 1999-04-15

Similar Documents

Publication Publication Date Title
DK0971713T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser
HRP20000292B1 (en) 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
DK0804196T3 (da) Anvendelse af serotoninantagonister (5HT 3) til behandling af fibromyalgia
TR199801348T2 (xx) Heterosikl-kondanse morfinoid t�revleri(II).
DE59707502D1 (de) Holzschutzmittel für den nachschutz
DE69525847D1 (de) Zusammensetzungen von opioid antagonisten mit selektiven serotonin-aufnahme inhibitoren, zur behandlung von alkoholismus und alkohoabhängigkeit
ID18142A (id) Inhibitor metaloprotease 1,4-heterosiklik
DE60120494D1 (de) Substituieten triazoldiamin derivaten und ihre verwendung als kinase inhibitoren
FI945411A (fi) Viilentäviä koostumuksia
EA200300906A1 (ru) Новые спиротрициклические производные и их применение в качестве ингибиторов фосфодиэстеразы-7
DE69526677D1 (de) Aromatische heterocyclische derivate als enzyminhibitoren
NO983189L (no) Nye substituerte imidazolforbindelser
EA199800633A1 (ru) Новые замещенные производные имидазола
ATE148130T1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
TR200000374T2 (tr) Akut akciğer harabiyeti ve fibrozitinin alfavbeta6 antagonistleriyle tedavisi.
DE69924641D1 (de) Behandlung von asthma anhand von mek-inhibitoren
TR199801255T2 (xx) Vitronektin resept�r antagonistleri.
EA200000351A1 (ru) Лечение кондуктивных нарушений
DE69840603D1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
DK0758890T3 (da) Anvendelse af NO indfangere, inhibitorer eller antagonister ved behandling af migræne
MXPA03011121A (es) Metodo para tratar materiales de tejido fibrosos.
AR028730A1 (es) Procedimiento para encontrar compuestos que son adecuados para el tratamiento y/o la profilaxis de la obesidad y utilizacion de dichos compuestos
DK0824350T3 (da) Anvendelse af et antimykotikum
EA200100517A1 (ru) Антагонисты 5ht1 для антидепрессантной терапии
ES2146249T3 (es) Composicion farmaceutica para tratar la impotencia que contiene un inhibidor alfa-1 y un inhibidor alfa-2.